• 00Days to go

Partnership Opportunities

The 15th Asia-Oceania ORL-HNS Congress 2023 theme is “Reaching Out – Maximising regional cooperation and resources to advance patient care”, and with expectations of 1,200 attendees, we hope that this congress will creating a lasting legacy for excellence in surgery and collaboration in the field of Otolaryngology Head and Neck Surgery for the region.

Principal partners

Major partners

Supporting partners


Congress Co-Hosts


Reasons to be involved:

Strengthen your brand in the market

Aligning your company with this powerful educational and international experience demonstrates your commitment to assisting professional development and further strengthens your brand within the market.

Heightened Visibility

You will have significant exposure prior to the congress through the website and marketing materials. There is no better way to position your organisation to up to 1,200 surgeons, otolaryngologists and allied health professionals from around the world.

Stand out from the crowd

Create your competitor difference by producing a unique and dynamic presence at the congress exhibiting.

Create your competitor difference by producing a unique and dynamic presence at the congress exhibiting.

Have you missed getting together in a room to talk in-person? This congress will give you limitless opportunities to meet and move forward with your business partners.

Network in an educational and social environment

Networking develops quality business relationships by having direct one to one engagement in a relaxed environment. Meet at one of our many social events or in the exhibition from across the globe.

Partnership Prospectus

BCEC's Floorplan

Applications for partnership and exhibition space are now open

For all partnership or exhibition enquiries, please contact our congress secretariat and industry liaison

Thomas Howden
Partnership Director

Medtronic ENT

Medtronic ENT providing solutions for over 20 years for Ear (Otological) Nose (Rhinology) and Throat (Laryngology/Head & Neck Cancer) Conditions. Treating patients with Chronic ENT conditions from Otological or Hearing disruption due to infection, congenital conditions, and trauma. Rhinology for Chronic Rhinosinusitis and upper nasal airway obstruction due to sinus disease pathology. Tracheal airway conditions that obstruct laryngeal structures including tracheal papilloma to Thyroidectomy and Head & Neck cancer conditions. We look forward to partnering with you.

3D Matrix

Since the inceptions of 3-D Matrix as a spinoff from MIT in 2004, 3-D Matrix has grown to become leading global peptide solutions company headquartered in Tokyo, Japan. With offices serving the Americas, Europe and Asia our employees together with our partners and distributor serve research scientists, healthcare providers and patients around the globe.

Due to the highly vascular nature of nasal tissue, post-operative haemostasis has always been a concern. The use of tamponade through the insertion of nasal packing is still commonly used but may be at the expense of patient comfort. Excessive pressure caused by tamponade may also be detrimental to the outcomes of delicately performed sinus surgery.

PuraStat® is a slightly viscous solution of RADA16 synthetic peptides. Contact between PuraStat® and blood causes the peptide solution to be neutralized and exposed to ions, resulting in the formation of ß-sheets that then form a 3-dimensional scaffold structure that is instantaneous, causing a physical (mechanical) closing of the superficial part of the broken blood vessel, resulting in haemostasis (induces natural blood coagulation).

Advanced Bionics

Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world.  Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best.  AB offers the most sophisticated cochlear implant systems on the market, the HiResolutionTM Bionic Ear System, with five times more sound resolution than its competitors.


Chitogel is a global medical device company, offering a leading-edge wound healing gel for use in endoscopic sinus surgeries. The Chitogel Endoscopic Sinus Surgery Kit has been successful across global markets, including the U.S., New Zealand and Australia.

Optimising wound healing after sinus surgery is critical to achieving long term, positive patient outcomes. Chitogel is a clinically proven hydrogel that is designed to support rapid wound healing, minimise adhesions, preserve structural integrity and address patient comfort.


Cochlear is the global leader in implantable hearing solutions, bringing sound to people with moderate to profound hearing loss. We aim to give our recipients the best lifelong hearing experience and access to innovative future technologies. For our professional partners, we offer the industry’s largest clinical, research and support networks.

ControMed Pty Ltd

Contromed Pty Ltd is an Australian based Medical Distribution Company, specialising in the Sales and Marketing of ENT products Nationally.

CoreMed Pty Ltd.

CoreMed is an Australian based medical distribution company, specialising in the field of ENT. CoreMed is the exclusive distributor for Spiggle & Theis, a world-renowned medical device manufacturer specialising in ENT instruments and consumables. We are also the Australian Distributors for inomed for ENT/Thyroid Nerve Monitoring.

Customised Compounding

Customised Compounding specialises in customising medications to suit individual needs. Our pharmacists have over 100 years of pharmacy experience. Our facility  NATA/ISO certified, has state-of-the art compounding equipment and uses only USP or BP grade ingredients to compound both non-sterile and sterile preparations to suit both doctor and patient’s needs. 

ENT Technologies Pty Ltd

ENT Technologies Pty Ltd, specialises in the formulation, development and delivery of novel pharmaceutical preparations for the management of both acute and chronic pathologies of both nasal and sinus cavities. Activities are now expanding to novel therapies for the treatment of Laryngopharyngeal Reflux and other laryngeal pathologies.

The company has recently been purchased by Aspen Pharmacare Australia and will experience an increased presence in upper airway disease management as significant funding is now being allocated to research projects.

Karl Storz Endoscopy Australia

Since its beginnings in 1945, the KARL STORZ family company has grown into a global manufacturer and distributor of endoscopes, medical instruments, and devices. We are no giant on an international scale but a leader in the things that matter: creativity, flexibility, and expertise.

From basic equipment for the ENT practice and outpatient settings to complete sets of endoscopic and surgical instruments through to the high-technology system for video-assisted endoscopy, the medical practitioner receives everything from one source: Perfectly matched endoscopes, instruments and units in excellent quality. 

Visit the KARL STORZ website www.karlstorz.com to find out more about the complete KARL STORZ range.



MED-EL offers the widest range of implantable and non-implantable solutions to treat all degrees of hearing loss across 124 countries and more than 4000 clinics worldwide. Our hearing solutions include cochlear and middle ear implant systems, a system for electric acoustic stimulation, implantable and surgery-free bone conductors, and brainstem implants.

The Royal Australasian College of Surgeons (RACS)

RACS is the leading advocate for surgical standards, professionalism and surgical education in Australia and New Zealand. The College is a not-for-profit organisation that represents more than 7,000 surgeons and 1,300 surgical trainees and International Medical Graduates.

The College provides continuous professional development, training and accreditation for surgeons. There are nine surgical specialties in Australasia being: Cardiothoracic surgery, General surgery, Neurosurgery, Orthopaedic surgery, Otolaryngology Head-and-Neck surgery, Paediatric surgery, Plastic and Reconstructive surgery, Urology and Vascular surgery.

RhinoSurgical | KURZ

Rhino Surgical Australia Pty Ltd is a new generation healthcare company. We are a leading provider of evidence-based technologies for ENT specialties. We are proud to provide a significant and sustainable impact on healthcare by delivering technologies that enhance clinical care and satisfy the growing economic needs of our customers.

Stark Medical Pty Ltd

Stark Medical is an Australian owned distributor for specialty products including high quality equipment from ATMOS including Microscopes, Patient Chairs, Suction Pumps and Workstations, Instruments from NOPA and consumables from Sheffmed. 


Tristel is the global leader in chlorine dioxide disinfectant solutions for medical devices and healthcare surfaces. Its lead technology has been a ground-breaking innovation in the world of Infection Prevention. Tristel has been providing hospitals around the world with the safest, fastest and smartest disinfectant solutions for over two decades.


VorOtek was founded in 1971 by Australian ENT surgeon Dr John Vorrath. For over fifty years Dr Vorrath and VorOtek have been developing and manufacturing fully integrated optical systems with illumination.  The aim has always been to provide users with products which enhance their capability for examination, instrumentation and procedures

Carl Zeiss Pty Ltd

The Carl Zeiss Group is a leading group of companies operating worldwide in the optical and opto-electronic industries.

We hope to see you at the ZEISS booth during the 15th Asia Oceania ORL-HNS Congress so that you may experience the TIVATO 700 and EXTARO 300 surgical microscopes. These microscopes allow otolaryngology and head & neck surgeons to fulfil their clear need for premium optical performance in the operating theatre. 

INLINE Imaging Technology

INLINE Imaging Technology specialises in the supply and installation of high-end imaging technology products and solutions to the medical and dental sectors. We are an Australian owned company and can confidently claim to be experts with over 25 years industry experience. We continuously research new technologies and equipment, staying at the forefront of industry developments, ensuring we continue to offer innovative, competitive and compatible imaging solutions into the future.

Prof Sarah Wise

Emory University School of Medicine

Sarah K. Wise, MD, MSCR is Professor of Otolaryngology-Head and Neck Surgery at Emory University in Atlanta, Georgia. She is the Emory Otolaryngology Residency Program Director, Rhinology Fellowship Director, and Director of Otolaryngic Allergy. Dr. Wise completed medical school at the University of Texas Health Science Center San Antonio, residency at Emory University and rhinology fellowship at the Medical University of South Carolina. Dr. Wise has served on the Board of Directors of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. She will become President of the American Rhinologic Society in September 2022, serving as the Society’s first female president. Her clinical interests include inflammatory rhinology, otolaryngic allergy, relationship of allergy and chronic rhinosinusitis, and cerebrospinal fluid leaks. Dr. Wise lectures nationally and internationally. Her most notable publication is the International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis, where she served as first author/primary editor.

Sponsor Name

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.